Body Volume Regulation in Pulmonary Arterial Hypertension With Right Ventricular Failure

NCT00811486 · clinicaltrials.gov ↗

NA

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Only 1 patient recruited, and he withdrew

Conditions

Right Heart Failure
Pulmonary Hypertension

Interventions

DRUG: Spironolactone and conivaptan

Sponsor

University of Colorado, Denver